Juthaporn Ponphaiboon

Dr. Juthaporn Ponphaiboon


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 July 2023 in Molecules
Verified
Journal Article
Open access
PDF file
JPJuthaporn Ponphaiboon
Juthaporn Ponphaiboon
WKWantanwa Krongrawa
Wantanwa Krongrawa
WAWah Wah Aung
Wah Wah Aung
NCNawinda Chinatangkul
Nawinda Chinatangkul
SLSontaya Limmatvapirat
Sontaya Limmatvapirat
Chutima LimmatvapiratChutima Limmatvapirat
Chutima Limmatvapirat
The present review explores the growing interest in the techniques employed for extracting natural products. It emphasizes the limitations of conventional extraction methods and introduces superior non-conventional alternatives, particularly ultrasound-assisted extraction. Characterization and quantification of bioactive constituents through chromatography coupled with spectroscopy are recommended, while the importance of method development and validation for biomarker quantification is underscored. At present, electrospun fibers provide a versatile platform for incorporating bioactive extracts and have extensive potential in diverse fields due to their unique structural and functional characteristics. Thus, the review also highlights the fabrication of electrospun fibers containing bioactive extracts. The preparation of biologically active extracts under optimal conditions, including the selection of safe solvents and cost-effective equipment, holds promising potential in the pharmaceutical, food, and cosmetic industries. Integration of experimental design into extraction procedures and formulation development is essential for the efficient production of health products. The review explores potential applications of encapsulating natural product extracts in electrospun fibers, such as wound healing, antibacterial activity, and antioxidant properties, while acknowledging the need for further exploration and optimization in this field. The findings discussed in this review are anticipated to serve as a valuable resource for the processing industry, enabling the utilization of affordable and environmentally friendly, natural, and raw materials.

23 February 2024 in Molecules
Verified
Journal Article
Open access
PDF file
JPJuthaporn Ponphaiboon
Juthaporn Ponphaiboon
SLSontaya Limmatvapirat
Sontaya Limmatvapirat
Chutima LimmatvapiratChutima Limmatvapirat
Chutima Limmatvapirat
This study investigates the development of an oil-in-water (O/W) emulsion enriched with a high concentration of ostrich oil, recognized for its abundant content of oleic acid (34.60 ± 0.01%), tailored for skincare applications. Using Span and Tween emulsifiers, we formulated an optimized emulsion with 20% w/w ostrich oil and a 15% w/w blend of Span 20 and Tween 80. This formulation, achieved via homogenization at 3800 rpm for 5 min, yielded the smallest droplet size (5.01 ± 0.43 μm) alongside an appropriate zeta potential (−32.22 mV). Our investigation into the influence of Span and Tween concentrations, types, and ratios on the stability of 20% w/w ostrich oil emulsions, maintaining a hydrophile–lipophile balance (HLB) of 5.5, consistently demonstrated the superior stability of the optimized emulsion across various formulations. Cytotoxicity assessments on human dermal fibroblasts affirmed the safety of the emulsion. Notably, the emulsion exhibited a 52.20 ± 2.01% inhibition of linoleic acid oxidation, surpassing the 44.70 ± 1.94% inhibition observed for ostrich oil alone. Moreover, it demonstrated a superior inhibitory zone against Staphylococcus aureus (12.32 ± 0.19 mm), compared to the 6.12 ± 0.15 mm observed for ostrich oil alone, highlighting its enhanced antioxidant and antibacterial properties and strengthening its potential for skincare applications. The optimized emulsion also demonstrates the release of 78.16 ± 1.22% of oleic acid across the cellulose acetate membrane after 180 min of study time. This successful release of oleic acid further enhances the overall efficacy and versatility of the optimized emulsion. Stability assessments, conducted over 6 months at different temperatures (4 °C, 25 °C, 45 °C), confirmed the emulsion’s sustained physicochemical and microbial stability, supporting its promise for topical applications. Despite minor fluctuations in acid values (AV) and peroxide values (PV), the results remained within the acceptable limits. This research elucidates the crucial role of emulsification in optimizing the efficacy and stability of ostrich oil in skincare formulations, providing valuable insights for practical applications where stability is paramount.

16 January 2023 in Antibiotics
Verified
Journal Article
Open access
PDF file
WAWah Wah Aung
Wah Wah Aung
KPKanokpon Panich
Kanokpon Panich
SWSuchawalee Watthanophas
Suchawalee Watthanophas
SNSutada Naridsirikul
Sutada Naridsirikul
JPJuthaporn Ponphaiboon
Juthaporn Ponphaiboon
Chutima LimmatvapiratChutima Limmatvapirat
Chutima Limmatvapirat
Senna alata leaves display various biological activities as a result of their rhein and phenolic composition. The objective of this study was to develop bioactive de-chlorophyll rhein-rich S. alata extracts. The rhein content was quantified using a validated high-performance liquid chromatography–diode array detection (HPLC–DAD) method. The best process parameters for maximizing rhein were established using ultrasound-assisted extraction (UAE). The optimal conditions for the parameters were determined using the Box–Behnken design (BBD); 95% v/v ethanol was used as the extraction solvent at 59.52 °C for 18.4 min with a solvent-to-solid ratio of 25.48:1 (mL/g) to obtain the predicted value of rhein at 10.44 mg/g extract. However, the color of the rhein-rich extract remained dark brown. For the removal of chlorophyll, liquid–liquid extraction with vegetable oils and adsorption with bleaching agents were employed. The bleaching agents were significantly more effective at removing chlorophyll and had less of an effect on the reduction in rhein content than vegetable oils. The presence of rhein and phenolics in the de-chlorophyll extracts might be responsible for their antioxidant, anti-inflammatory, and antibacterial activities. These findings indicate that rhein-rich extract and its de-chlorophyll extracts possess sufficient biological activities for the further development of cosmeceuticals and pharmaceuticals.

17 August 2024 in Foods
Verified
Journal Article
Open access
PDF file
JPJuthaporn Ponphaiboon
Juthaporn Ponphaiboon
SLSontaya Limmatvapirat
Sontaya Limmatvapirat
Chutima LimmatvapiratChutima Limmatvapirat
Chutima Limmatvapirat
This study aimed to develop a high-quality dry emulsion incorporating omega-3, 6, and 9 fatty acid-rich ostrich oil for use as a dietary supplement. Extracted from abdominal adipose tissues using a low-temperature wet rendering method, the ostrich oil exhibited antioxidant properties, favorable physicochemical properties, microbial counts, heavy metal levels, and fatty acid compositions, positioning it as a suitable candidate for an oil-in-water emulsion and subsequent formulation as a dry emulsion. Lecithin was employed as the emulsifier due to its safety and health benefits. The resulting emulsion, comprising 10% w/w lecithin and 10% w/w ostrich oil, was stable, with a droplet size of 3.93 ± 0.11 μm. This liquid emulsion underwent transformation into a dry emulsion to preserve the physicochemical stability of ostrich oil, utilizing Avicel® PH-101 or Aerosil® 200 through a granulation process. Although Aerosil® 200 exhibited superior adsorption, Avicel® PH-101 granules surpassed it in releasing the ostrich oil emulsion. Consequently, Avicel® PH-101 was selected as the preferred adsorbent for formulating the ostrich oil dry emulsion. The dry emulsion, encapsulated with a disintegration time of 3.11 ± 0.14 min for ease of swallowing, maintained microbial loads and heavy metal contents within acceptable limits. Presented as granules containing butylated hydroxytoluene, the dry emulsion showcased robust temperature stability, suggesting the potential incorporation of animal fat into dry emulsions as a promising dietary supplement.

8 March 2025 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
JPJuthaporn Ponphaiboon
Juthaporn Ponphaiboon
WKWantanwa Krongrawa
Wantanwa Krongrawa
SLSontaya Limmatvapirat
Sontaya Limmatvapirat
STSukannika Tubtimsri
Sukannika Tubtimsri
AJAkanitt Jittmittraphap
Akanitt Jittmittraphap
Chutima LimmatvapiratChutima Limmatvapirat
Chutima Limmatvapirat
Background/Object: This study investigates the in vitro antiviral potential of D-limonene (DLM), monolaurin (ML), and cetylpyridinium chloride (CPC) in formulations targeting SARS-CoV-2 and influenza viruses. The aim was to develop oral and nasal formulations with optimized concentrations of these active ingredients to evaluate their efficacy, safety, and stability. Methods: Oral (formulation D) and nasal (formulation E) products were developed using specific concentrations of DLM (0.2–0.3% w/w), ML (0.1–0.2% w/w), and CPC (0.05–0.075% w/w). In vitro virucidal activity assays were conducted to assess the antiviral efficacy of the formulations against SARS-CoV-2 and influenza viruses. Stability testing was also performed under various storage conditions. Results: Formulation D (0.3% w/w DLM, 0.2% w/w ML, 0.05% w/w CPC, and 1.5% w/w Cremophor RH40) demonstrated a 3.875 ± 0.1021 log reduction and 99.99 ± 0.0032% efficacy against SARS-CoV-2 within 120 s. Formulation E (0.2% w/w DLM, 0.05% w/w CPC, and 0.75% w/w Cremophor RH40) showed a 2.9063 ± 0.1197 log reduction and 99.87 ± 0.0369% efficacy against SARS-CoV-2. Both formulations achieved >99.99% efficacy and log reductions exceeding 4.000 against various influenza strains. Stability testing confirmed optimal performance at 4 °C with no microbial contamination. Conclusions: The findings suggest that both formulations exhibit broad-spectrum antiviral activity against SARS-CoV-2 and influenza viruses in vitro. These results support their potential for further clinical evaluations and therapeutic applications, particularly in oral and nasal spray formulations.

12 December 2025 in Ultrasonics Sonochemistry
Verified
Journal Article
Open access
JPJuthaporn Ponphaiboon
Juthaporn Ponphaiboon
WKWantanwa Krongrawa
Wantanwa Krongrawa
SLSontaya Limmatvapirat
Sontaya Limmatvapirat
Chutima LimmatvapiratChutima Limmatvapirat
Chutima Limmatvapirat
This study optimized ultrasound-assisted extraction (UAE) conditions to maximize bioactive compounds from Momordica charantia L. (Okinawan bitter melon) fruit using response surface methodology (RSM). A three-factor, three-level Box-Behnken design assessed the effects of acoustic intensity, duty cycle, and extraction time on extraction yield, total phenolic content (TPC), antioxidant activity (DPPH and FRAP assays), α-glucosidase inhibitory activity, and charantin content. Acoustic intensity had the greatest impact, followed by duty cycle and extraction time. The optimal conditions were 85 W·cm-2 acoustic intensity, 0.83 s-1 duty cycle, and 13.20 min extraction time, yielding 35.80 % extract, 847.91 mg GAE/100 g extract TPC, IC50 of DPPH at 119.08 µg/mL, FRAP value of 148.76 mg AAE/g extract, α-glucosidase inhibition of 41.60 mg acarbose/g extract, and charantin content of 5.83 mg/g extract. Experimental values closely matched predictions, confirming model validity. This optimized UAE method provides an efficient approach for extracting bioactive compounds from M. charantia L., ensuring high yield and biological activity. The findings offer valuable insights for industrial-scale extraction and potential applications in functional foods, pharmaceuticals, and nutraceuticals.